Andrew serves as a partner on the medical devices team at Deerfield, and his previous positions include work as principal at Longitude Capital and an associate in JPMorgan’s healthcare investment banking practice. He has been independently funded by the NIH and authored over 30 publications.

Andrew holds an M.D. from the Mayo Clinic, an M.P.H. in quantitative methods from Harvard University, an M.B.A from Harvard Business School, and a B.S. with honors in biology from the Pennsylvania State University.